065660.KQ
Anterogen.Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 14,840.00
−0.34%Margins
Gross margin
29.7%
EBITDA margin
-21.4%
EBIT margin
-29.4%
Net margin
-19.3%
FCF margin
-16.9%
-2.0%
Return on equity
-2.0%
Return on assets
-3.1%
Return on invested capital
0.10x
Asset turnover
-KRW 1.1B
Cash from operations
KRW 4.3K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026